STRATEGIC PARTNERSHIPS

Partner around a defined asset, workflow or market.

Disease Intelligence should avoid vague partnership announcements. Each collaboration should have a clear contribution, deliverable, evidence objective and commercial or public-interest path.

Design partner

Co-design and validate one workflow with real users and agreed evidence measures.

Best for: hospitals, CROs, research institutes.

Data / interoperability partner

Connect standards, datasets or controlled APIs under explicit governance.

Best for: EHR, FHIR, registries, health-data infrastructure.

Distribution partner

Embed Disease Intelligence into an existing institutional network or workflow.

Best for: hospital groups, professional networks, software vendors.

Research partner

Independently validate performance, safety, human factors or health-system impact.

Best for: universities and independent research groups.

National / regional partner

Deploy a governed public-sector intelligence layer with local data and accountability.

Best for: health authorities and public systems.

Strategic capital partner

Combine capital with market access, expertise or institutional distribution.

Best for: strategic investors and corporate venture.